Impulse control disorder, lysosomal malfunction and ATP13A2 insufficiency in Parkinsonism-Reference-Cited by-同舟云学术

Impulse control disorder, lysosomal malfunction and ATP13A2 insufficiency in Parkinsonism

Published:2017-01-24 Issue:2 Volume:44 Page:172-179
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Liu Jun-Ping¹²³,Li Jianfeng¹,Lu Yanhua¹,Wang Lihui¹,Chen Gang¹

Affiliation:

1. School of Medicine; Institute of Ageing Research; Hangzhou Normal University; Hangzhou Zhejiang Province China

2. Department of Molecular and Translational Science; Faculty of Medicine; Hudson Institute of Medical Research; Monash University; Clayton VIC Australia

3. Department of Immunology; Faculty of Medicine; Central Clinical School; Monash University; Prahran VIC Australia

Funder

National Basic Research Program of China

National Natural Science Foundation of China

National Health and Medical Research Council of Australia

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12714/fullpdf

Reference115 articles.

1. Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease;Potenza;Nat Clin Pract Neurol,2007

2. Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease;Carriere;Neurology,2015

3. Clinical spectrum of impulse control disorders in Parkinson's disease;Weintraub;Mov Disord,2015

4. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease;Napier;Mov Disord,2015

5. Multiple accounts of adolescent impulsivity;Steinberg;Proc Natl Acad Sci U S A,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy;Biosensors;2023-07-12

2. ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology;The Journal of Biomedical Research;2022

3. Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies;Clinica Chimica Acta;2019-08

4. Mitochondrial dysfunction in ATP13A2 carriers;Brain and Development;2019-02